$19.81 Billion Large Molecule Drug Substance Contract Development and Manufacturing Organization (CDMO) Market Analysis - Global Industry Size, Share, Trends, Opportunity & Forecast, 2019-2029F
14 mai 2024 10h31 HE
|
Research and Markets
Dublin, May 14, 2024 (GLOBE NEWSWIRE) -- The "Large Molecule Drug Substance CDMO Market - Global Industry Size, Share, Trends, Opportunity & Forecast, 2019-2029F" report has been added to ...
Small Molecule Innovator API CDMO Research Report 2024: Global Market to Reach $47.14 Billion by 2030 driven by Increasing Demand for Small Molecule Drugs, and Surge in Clinical Trials
14 mai 2024 09h31 HE
|
Research and Markets
Dublin, May 14, 2024 (GLOBE NEWSWIRE) -- The "Small Molecule Innovator API CDMO Market Size, Share & Trends Analysis Report By Stage Type (Preclinical, Clinical, Commercial), By Customer Type,...
New Drug Approvals and Their Contract Manufacture 2024 Report - NDA Drug and Vaccine Approvals and the Levels of Outsourcing Associated with NDA Sub Segments
13 mai 2024 07h57 HE
|
Research and Markets
Dublin, May 13, 2024 (GLOBE NEWSWIRE) -- The "New Drug Approvals and Their Contract Manufacture - 2024 Edition" report has been added to ResearchAndMarkets.com's offering.This report is the 14th...
Avid Bioservices to Participate at Upcoming Investor Conferences
07 mai 2024 16h05 HE
|
Avid Bioservices, Inc
TUSTIN, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Successful FDA Inspection at Dipharma Facility in Kalamazoo, MI, USA
07 mai 2024 10h00 HE
|
Dipharma Francis S.r.l
Dipharma Inc. has been inspected by the US FDA and has received the EIR, satisfactorily closing the inspection process.
Small Molecule CMO/CDMO Market Outlook 2024-2033: Rising Focus on Personalized Medicine and Niche Therapies Worldwide
02 mai 2024 06h19 HE
|
Research and Markets
Dublin, May 02, 2024 (GLOBE NEWSWIRE) -- The "Small Molecule CMO/CDMO Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The global small molecule CMO/CDMO market...
Inhalation CDMO Global Research Report 2024-2033: Integration of AI and ML Enhances Capabilities, Biopharmaceutical Inhalation Therapies Rapidly Expand, Patient-Centric Solutions Take Center Stage
25 avr. 2024 11h16 HE
|
Research and Markets
Dublin, April 25, 2024 (GLOBE NEWSWIRE) -- The "Inhalation CDMO Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The inhalation CDMO market size has grown...
Integer Holdings Corporation Reports First Quarter 2024 Results
25 avr. 2024 08h00 HE
|
Integer Holdings Corporation
~ Strong start to the year with 1Q24 financial results ~~ Reiterate 2024 financial outlook ~ PLANO, Texas, April 25, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) today...
Mithra secures court protection measures to advance monetization process
22 avr. 2024 01h00 HE
|
Mithra Pharmaceuticals
Court Grants "Transfer under Judicial Supervision" for CDMO facility, safeguarding Mithra's activities and expediting the M&A process for its Contract Development and Manufacturing...
CoreRx, Inc. Completes Acquisition of Societal CDMO, Inc.
08 avr. 2024 16h05 HE
|
Societal CDMO, Inc.; CoreRx, Inc.
CLEARWATER, Fla., April 08, 2024 (GLOBE NEWSWIRE) -- CoreRx, Inc. (“CoreRx”) today announced that it has completed its acquisition of Societal CDMO, Inc. (“Societal CDMO”) (Nasdaq: SCTL), a contract...